Aramark (ARMK): What to Expect from Q2 Fiscal 2026 Earnings
Key Takeaways
- Analysts expect Q2 fiscal 2026 revenue of approximately $4.76 billion, reflecting about 11% year-over-year growth.
- Consensus adjusted EPS estimate stands at $0.47-$0.48 per share, implying strong 38%-41% growth from prior year.
- Company reaffirmed FY2026 guidance for 7%-9% organic revenue growth and adjusted EPS of $2.18-$2.28.
- Key focus on FSS United States and International segments, with calendar shift tailwind anticipated for Q2.
- Robust net new business pipeline supports outlook, targeting 4%-5% growth for the full year.
- Investors watching margins amid food cost inflation and new contract ramps.
Earnings Context and Why It Matters
As someone who follows the food services and facilities management space closely, I see ARMK as a steady player navigating a competitive environment driven by demand from education, healthcare, and business sectors. This upcoming Q2 fiscal 2026 earnings report, set for today, May 12, 2026, feels particularly important. It comes on the heels of a strong Q1, where revenue reached $4.83 billion, up 6% year-over-year, even with a headwind from the fiscal 2025 53rd week calendar shift. From what I see, investors will be looking for signs of continued organic growth, new business wins, and steady progress toward full-year goals, especially as inflation moderates and business & industry (B&I) volumes recover. Solid results here could further validate the company's multi-year turnaround efforts.
Earnings Expectations
Wall Street's projections point to consolidated revenue of around $4.76 billion for Q2 fiscal 2026, which ended roughly in April 2026, marking about 11% growth from the $4.33 billion reported in the year-ago quarter. The consensus for adjusted EPS sits at $0.47 to $0.48, representing a 38%-41% jump from $0.34 last year, fueled by operational leverage and contributions from new business. Expectations break down to FSS United States revenue at $3.39 billion (up 10.9%) and FSS International at $1.39 billion (up 14%).
Q1 demonstrated real resilience: organic revenue grew 5% to a total of $4.8 billion, adjusted EPS held flat at $0.51 (which would have been up 13% without the shift), and adjusted operating income (AOI) rose 1%. Management has flagged a tailwind for Q2 from that prior 53rd week shift. The full-year guidance remains unchanged: revenue of $19.55-$19.95 billion (7%-9% organic growth), AOI growth of 12%-17%, adjusted EPS of $2.18-$2.28 (20%-25% growth), and leverage below 3.0x (net debt to AOI). I'll be paying close attention to net new business (targeting 4%-5%), client retention rates, and margins in the face of food and labor cost pressures.
Market Reaction and Investor Sentiment
One thing that stands out to me is the cautiously optimistic sentiment around ARMK heading into these results. Shares have held up well since the Q1 revenue and EPS beats, posting modest gains even amid broader market swings. Analysts highlight upside potential in B&I and education volumes, though risks like contract delays or inflation-driven margin squeezes remain on the radar. Historically, the stock has reacted positively to beats—for instance, up 2% after-hours following Q1—though reaffirmation of guidance will likely be the deciding factor. Options pricing suggests limited volatility is baked in.
AI Screener: A Tool I Rely On for Peers Comparison
I also checked this using Tickeron’s AI Screener to see how ARMK stacks up against peers on technical patterns, fundamentals, and trends. This AI-powered tool scans thousands of stocks and ETFs with customizable filters like industry, market cap, and performance metrics, helping pinpoint opportunities more efficiently than manual reviews. In my view, it's a practical way to enhance analysis without the guesswork—worth exploring if you're screening for similar names.
Forward Outlook and Key Factors to Monitor
In my view, Aramark's reaffirmed FY2026 guidance signals real confidence, with organic revenue growth targeted at 7%-9% and adjusted EPS expanding 20%-25% to $2.18-$2.28. This outlook builds directly on Q1 momentum, including net new business wins in healthcare (such as RWJ Barnabas), education, corrections, sports, and mining, plus record retention above 95%.
I'm watching Q2 progress toward the 4%-5% net new business target closely, backed by a strong pipeline where over 40% comes from first-time outsourcing. The calendar shift tailwind should support FSS United States revenue growth, particularly in B&I and higher education.
Other elements to track include AI-driven efficiencies in the supply chain, group purchasing organization (GPO) spend surpassing $20 billion, and recent debt repricings that lower interest expenses. Keep an eye on cost trends—food and labor inflation is tracking plans—and progress toward leverage under 3.0x. With upcoming contract ramps and 17 straight quarters of double-digit international growth, these results will offer insight into demand resilience in an uncertain economy.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
ARMK's Stochastic Oscillator is sitting in oversold zone for 1 day
Be on the lookout for a price bounce soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +1.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARMK advanced for three days, in 214 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
ARMK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 216 of 308 cases where ARMK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
Bearish Trend Analysis
The 10-day RSI Indicator for ARMK moved out of overbought territory on August 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 20 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARMK as a result. In 42 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
The Moving Average Convergence Divergence Histogram (MACD) for ARMK turned negative on August 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 24 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 46%.
ARMK moved below its 50-day moving average on September 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ARMK crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARMK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ARMK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.384) is normal, around the industry mean (8.023). P/E Ratio (39.476) is within average values for comparable stocks, (60.976). Projected Growth (PEG Ratio) (0.879) is also within normal values, averaging (1.977). Dividend Yield (0.009) settles around the average of (0.013) among similar stocks. P/S Ratio (0.776) is also within normal values, averaging (9.694).
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a holding company with interests in food services and facilities management
Industry OfficeEquipmentSupplies
Advertisement